Pancreatic Cancer Research

ResearcherBrown UniversityActive in the last 2 years

Anna D. Louie

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8394-6106; OpenAlex author ID A5065299152. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 3 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. Correction: ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer. First author DOI 10.1158/1535-7163.mct-26-0613↗
  2. TRAIL receptor agonist TLY012 in combination with PD-1 inhibition promotes tumor regression in an immune-competent mouse model of pancreatic ductal adenocarcin… Co-author DOI 10.62347/roat5658↗
  3. ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer. First author DOI 10.1158/1535-7163.mct-20-0962↗
  4. Providing Appropriate Pancreatic Cancer Care for People Experiencing Homelessness: A Surgical Perspective. Co-author DOI 10.1200/edbk_100027↗
  5. Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fphar.2021.751568↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wafik S. El‐Deiry · 4 shared papers, 2021–2026 · strength 1.01
  2. Isacco Ferrarini · 2 shared papers, 2021–2026 · strength 0.62
  3. Thomas J. Miner · 2 shared papers, 2021–2025 · strength 0.42
  4. Alexander Grenander Raufi · 1 shared paper, 2021 · strength 0.12
  5. Attila A. Seyhan · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.